Publications by authors named "M M Bader El-Dein"

In recent years, bone marrow derived mesenchymal stem cells (BM-derived MSCs) have emerged as a powerful cell-based therapy for various diseases, including male infertility. Demonstrating the efficiency of BM-derived MSCs transplantation by different routes of injection to home and repair testis of busulfan-induced azoospermic rats. In the present study, rat BM-derived MSC was isolated and characterized for mesenchymal &hematopoietic markers using flow-cytometry.

View Article and Find Full Text PDF

<b>Background and Objective:</b> Cerebellar fluorosis is a health issue associated with excessive exposure to fluoride (F) either in direct or indirect ways as pesticides, drinking water and caries preventing prescriptions. It is characterized by elevation in oxidative stress, inflammation, demyelination and Purkinje cell loss. <i>Moringa oleifera</i> (M), is a widely cultivated plant used as a health-booster agent in modulating various disorders because of its high content of vitamins and minerals.

View Article and Find Full Text PDF

Ganoderma is a well-known genus of medicinal mushrooms. The biological activity of the fruiting bodies of G. mbrekobenum (previously identified as Ganoderma sp.

View Article and Find Full Text PDF

Background And Objective: An abnormality in muscular tone, lack of postural control, and a lack of coordination are all linked to the retention of primitive and immature postural reflexes. The Purpose of this study aimed of detecting which therapeutic approach is more effective in integrating retained primitive reflexes, either Masgutova neuro-sensorimotor reflex integration or Sensory integration (SI) program.

Methods: Forty children with spastic diplegic cerebral palsy (CP) (11 girls and 29 boys), involved in the current study and their ages ranged from 3 to 6 years old.

View Article and Find Full Text PDF
Article Synopsis
  • A randomized, double-blind, phase 2 trial assessed the safety and effectiveness of a new vaccine, NVSI-06-09, as a booster for UAE adults previously vaccinated with BBIBP-CorV.
  • * The trial involved 516 participants who received either NVSI-06-09 or continued with BBIBP-CorV, showing a similar low incidence of mild adverse reactions in both groups.
  • * Results indicated that NVSI-06-09 produced significantly higher neutralizing antibody levels against various SARS-CoV-2 variants, including significantly better responses against Omicron strains compared to BBIBP-CorV.
View Article and Find Full Text PDF